financetom
Business
financetom
/
Business
/
Top Premarket Gainers
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Top Premarket Gainers
Jul 1, 2024 5:20 AM

07:47 AM EDT, 07/01/2024 (MT Newswires) -- Chewy (CHWY) shares were up over 17% after stock influencer Keith Gill disclosed a 6.6% stake in the company.

Datasea ( DTSS ) stock was 9% higher following a 2.5% increase in the previous session.

Cassava Sciences ( SAVA ) shares were up 2%, shaving Friday's losses.

Price: 31.96, Change: +4.72, Percent Change: +17.33

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Select Water Solutions Keeps Dividend at $0.06 per Class A Share, Payable Aug. 16 to Holders as of Aug. 5
--Select Water Solutions Keeps Dividend at $0.06 per Class A Share, Payable Aug. 16 to Holders as of Aug. 5
Jul 26, 2024
05:27 AM EDT, 07/26/2024 (MT Newswires) -- Price: 11.49, Change: +0.26, Percent Change: +2.29 ...
3M's Q2 Adjusted Earnings Increase, Net Sales Decline
3M's Q2 Adjusted Earnings Increase, Net Sales Decline
Jul 26, 2024
06:58 AM EDT, 07/26/2024 (MT Newswires) -- 3M ( MMM ) reported Q2 adjusted earnings Friday of $1.93 per diluted share, up from $1.39 a year earlier. Analysts polled by Capital IQ expected $1.68. Net sales for the quarter ended June 30 were $6.26 billion compared with $6.28 billion a year earlier. Analysts polled by Capital IQ expected $5.83 billion....
Insulet expects to beat revenue estimates on strong insulin pump demand
Insulet expects to beat revenue estimates on strong insulin pump demand
Jul 26, 2024
July 26 (Reuters) - Insulet ( PODD ) reported preliminary second-quarter revenue above Wall Street estimates on Friday, as it benefited from strong demand for its insulin delivery devices. The Massachusetts-based company manufactures and sells insulin delivery devices, under brand Omnipod, which eliminate the need for multiple daily injections using syringes or insulin pens for people with insulin-dependent diabetes. The...
Bristol Myers second-quarter results beat expectations, helped by new drugs
Bristol Myers second-quarter results beat expectations, helped by new drugs
Jul 26, 2024
July 26 (Reuters) - Drugmaker Bristol Myers Squibb posted better-than-expected second-quarter results, driven by growth from new products like anemia treatment Reblozyl and heart drug Camzyos as well as from its top-seller, blood thinner Eliquis. The company also raised its earnings forecast for the full year. You're really seeing the transformation of our business to the new growth portfolio, Chief...
Copyright 2023-2026 - www.financetom.com All Rights Reserved